Get started
Live feed
·
SECFilingvia Quantisnow
Regeneron Pharmaceuticals Inc. logo

REGN: SEC Form 10-Q filed by Regeneron Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for REGN

Across the 20 sessions after earlier REGN headlines, the stock closed higher 11 times and lower 9 times, with a median move of 1.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

REGN close-to-close change in the session after earlier headlines
SessionEarlier headlineREGNSPY
Oct 26, 2026Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparednessand 1 other headline that session+0.3%+0.7%
Oct 16, 2026Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types-0.7%-1.1%
Oct 12, 2026Pasatru™ (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Patients During OPTIMA Trial Extension+2.2%-0.1%
Oct 6, 2026Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026+1.7%+0.5%
Oct 1, 2026Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)and 4 other headlines that session-3.1%+0.2%
Sep 25, 2026Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026-1.0%+0.5%
Quantisnow market dataNASDAQ
Regeneron Pharmaceuticals Inc. logo
REGN
Regeneron Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
1991
Get push alerts for REGN

Follow REGN and get a push notification the moment its next story breaks.

Full REGN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REGN (Regeneron Pharmaceuticals Inc.) and more on Quantisnow.